Namzaric (donepezil and memantine), also known as MDX-8704, ADS-8704, and Arimenda, is an approved therapy for moderate to severe Alzheimer’s disease. Allergan markets the treatment in the U.S. and ...
A study published in Journal of Neuropsychiatry and Clinical Neuroscience observed the efficacy of donepezil for addressing persistent verbal memory impair | Neuroscience ...
The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...
Depressive symptom is the most common type of psychiatric co-morbidity among persons with epilepsy. Epilepsy patients are identified as at higher risk of suffering depressive symptom explicitly in low ...
Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
Kathy Ingebrand started to notice something was off when she found herself being short with her family. She was becoming easily agitated, forgetting things and misplacing items.
However, given the upcoming patent expirations (rivastigmine going off-patent in 2007, galantamine in 2008, donepezil and memantine in 2010) and the likely entry of generics, the total value of ...
Alpha Cognition Inc. ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the ...